The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1485
January 4, 2016
View Complete Issue         Table of Contents 2019 
Naloxone (Narcan) Nasal Spray for Opioid Overdose
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Naloxone (Narcan) Nasal Spray for Opioid Overdose
January 4, 2016 (Issue: 1485)
The recent increase in deaths due to overdose of heroin and prescription opioids in the US has renewed interest in the opioid antagonist naloxone, particularly in making it available to first responders and to relatives and close friends of...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Naloxone (Narcan) Nasal Spray for Opioid Overdose
Article code: 1485a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.